Pubblicazioni scientifiche

Zamboglou C.; Peeken J.C.; Janbain A.; Katsahian S.; Strouthos I.; Ferentinos K.; Farolfi A.; Koerber S.A.; Debus J.; Vogel M.E.; Combs S.E.; Vrachimis A.; Morganti A.G.; Spohn S.K.B.; Shelan M.; Aebersold D.M.; Grosu A.L.; Ceci F.; Henkenberens C.; Kroeze S.G.C.; Guckenberger M.; Fanti S.; Belka C.; Bartenstein P.; Hruby G.; Scharl S.; Wiegel T.; Emmett L.; Arnoux A.; Schmidt-Hegemann N.S., Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer, «JAMA NETWORK OPEN», 2023, 6, pp. 1 - 13 [Articolo in rivista] Open Access

Palmerini E.; Frega G.; Gambarotti M.; Frisoni T.; Cesari M.; Bazzocchi A.; Miceli M.; Donati D.M.; Fanti S.; Nanni C.; Benini S.; Longhi A.; Paioli A.; Marrari A.; Hakim R.; Righi A.; Ibrahim T., NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report, «FRONTIERS IN ONCOLOGY», 2023, 13, pp. 1 - 6 [Articolo in rivista] Open Access

Vetrone L.; Mei R.; Bianchi L.; Giunchi F.; Farolfi A.; Castellucci P.; Droghetti M.; Presutti M.; Degiovanni A.; Schiavina R.; Brunocilla E.; D'Errico A.; Fanti S., Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging, «CANCERS», 2023, 15, pp. 1 - 13 [Articolo in rivista] Open Access

Bamias A.; Stenzl A.; Brown S.L.; Albiges L.; Babjuk M.; Birtle A.; Briganti A.; Burger M.; Choudhury A.; Colecchia M.; De Santis M.; Fanti S.; Fonteyne V.; Gallucci M.; Rivas J.G.; Huddart R.; Junker K.; Kroeze S.; Loriot Y.; Merseburger A.; Montironi R.; Necchi A.; Oing C.; Oldenburg J.; Ost P.; Pinkawa M.; Ribal M.J.; Roupret M.; Thoeny H.; Zilli T.; Hoskin P., Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty, «EUROPEAN UROLOGY», 2023, 84, pp. 381 - 389 [Articolo in rivista]

Kratochwil C.; Fendler W.P.; Eiber M.; Hofman M.S.; Emmett L.; Calais J.; Osborne J.R.; Iravani A.; Koo P.; Lindenberg L.; Baum R.P.; Bozkurt M.F.; Delgado Bolton R.C.; Ezziddin S.; Forrer F.; Hicks R.J.; Hope T.A.; Kabasakal L.; Konijnenberg M.; Kopka K.; Lassmann M.; Mottaghy F.M.; Oyen W.J.G.; Rahbar K.; Schoder H.; Virgolini I.; Bodei L.; Fanti S.; Haberkorn U.; Hermann K., Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT), «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2023, 50, pp. 2830 - 2845 [Articolo in rivista] Open Access

Zagni F.; Vichi S.; Paolani G.; Santoro M.; Della Gala G.; Strolin S.; Castellucci P.; Vetrone L.; Fanti S.; Morganti A.G.; Strigari L., A novel tool for predicting the dose distribution of non-sealed 188Re (Rhenium) resin in non-melanoma skin cancers (NMSC) patients, «MEDICAL PHYSICS», 2023, 50, pp. 4600 - 4612 [Articolo in rivista] Open Access

Fendler W.P.; Eiber M.; Beheshti M.; Bomanji J.; Calais J.; Ceci F.; Cho S.Y.; Fanti S.; Giesel F.L.; Goffin K.; Haberkorn U.; Jacene H.; Koo P.J.; Kopka K.; Krause B.J.; Lindenberg L.; Marcus C.; Mottaghy F.M.; Oprea-Lager D.E.; Osborne J.R.; Piert M.; Rowe S.P.; Schoder H.; Wan S.; Wester H.-J.; Hope T.A.; Herrmann K., PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2023, 50, pp. 1466 - 1486 [Articolo in rivista] Open Access

Bashir H.; Gul M.R.; Younis M.N.; Tulchinsky M.; Li Y.; Fanti S.; Alavi A., Nuclear Medicine - A Name for Now and the Future, «CLINICAL NUCLEAR MEDICINE», 2023, 48, pp. 315 - 317 [Articolo in rivista]

Nanni C.; Mosconi C.; Dragonetti V.; Barakat M.; Fraccascia N.; Cocozza M.A.; Brocchi S.; Palloni A.; Paccapelo A.; Brandi G.; Fanti S., Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma, «FRONTIERS IN MEDICINE», 2023, 10, pp. 1 - 9 [Articolo in rivista] Open Access

Scharl S.; Zamboglou C.; Strouthos I.; Farolfi A.; Serani F.; Lanzafame H.; Giuseppe Morganti A.; Trapp C.; Koerber S.A.; Debus J.; Peeken J.C.; Vogel M.M.E.; Vrachimis A.; Spohn S.K.B.; Ruf J.; Grosu A.-L.; Ceci F.; Fendler W.P.; Bartenstein P.; Kroeze S.G.C.; Guckenberger M.; Krafcsik M.; Klopscheck C.; Fanti S.; Hruby G.; Emmett L.; Belka C.; Stief C.; Schmidt-Hegemann N.-S.; Henkenberens C.; Mayer B.; Miksch J.; Shelan M.; Aebersold D.M.; Thamm R.; Wiegel T., Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study, «RADIOTHERAPY AND ONCOLOGY», 2023, 184, pp. 109678 - 109678 [Articolo in rivista]

Evangelista L.; Fanti S., PET/CT in Prostate Cancer, «CANCERS», 2023, 15, pp. 1 - 18 [Articolo in rivista] Open Access

Solomonidou N.; Germanou D.; Strouthos I.; Karagiannis E.; Farolfi A.; Koerber S.A.; Debus J.; Peeken J.C.; Vogel M.E.; Vrachimis A.; Spohn S.K.B.; Shelan M.; Aebersold D.; Grosu A.-L.; Ceci F.; Kroeze S.G.C.; Guckenberger M.; Fanti S.; Belka C.; Hruby G.; Scharl S.; Wiegel T.; Bartenstein P.; Henkenberens C.; Emmett L.; Schmidt-Hegemann N.S.; Ferentinos K.; Zamboglou C., PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2023, 50, pp. 2529 - 2536 [Articolo in rivista] Open Access

Vetrone L.; Cuzzani G.; Mei R.; Zanoni L.; Bertaccini A.; Bianchi L.; Castellucci P.; Gaudiano C.; Cappelli A.; Giunchi F.; Fanti S., Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge, «FRONTIERS IN ONCOLOGY», 2023, 13, pp. 1 - 5 [Articolo in rivista] Open Access

Delgado Bolton R.C.; Calapaqui Teran A.K.; Fanti S.; Giammarile F., The Concept of Strength Through Synergy Applied to the Search of Powerful Prognostic Biomarkers in Gastroesophageal Cancer: An Example Based on Combining Clinicopathological Parameters, Imaging-Derived Sarcopenia Measurements, and Radiomic Features, «CLINICAL NUCLEAR MEDICINE», 2023, 48, pp. 156 - 157 [Articolo in rivista]

Mattana F.; Zanoni L.; Nanni C.; Mosconi C.; Brocchi S.; Golfieri R.; Fanti S., Actionable imaging findings in the daily PET/CT scenario, «CLINICAL AND TRANSLATIONAL IMAGING», 2023, 11, pp. 127 - 139 [Articolo in rivista]

Seifert, R.; Emmett, L.; Rowe, S. P.; Herrmann, K.; Hadaschik, B.; Calais, J.; Giesel, F. L.; Reiter, R.; Maurer, T.; Heck, M.; Gafita, A.; Morris, M. J.; Fanti, S.; Weber, W. A.; Hope, T. A.; Hofman, M. S.; Fendler, W. P.; Eiber, M., Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2), «EUROPEAN UROLOGY», 2023, 83, pp. 405 - 412 [Articolo in rivista] Open Access

Mei R.; Kessler L.; Pabst K.M.; Weber M.; Schmidkonz C.; Rischpler C.; Zacho H.D.; Hope T.; Schwarzenbock S.M.; Allen-Auerbach M.; Emmett L.; Ferdinandus J.; Unterrainer M.; Schaarschmidt B.M.; Umutlu L.; Farolfi A.; Castellucci P.; Nanni C.; Telo S.; Fanti S.; Herrmann K.; Fendler W.P., 68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study, «THE JOURNAL OF NUCLEAR MEDICINE», 2023, 64, pp. 1043 - 1048 [Articolo in rivista] Open Access

Bianchi L.; Ceci F.; Balestrazzi E.; Costa F.; Droghetti M.; Piazza P.; Pissavini A.; Presutti M.; Farolfi A.; Mei R.; Castellucci P.; Gandaglia G.; Larcher A.; Robesti D.; Mottrie A.; Briganti A.; Morganti A.G.; Fanti S.; Montorsi F.; Schiavina R.; Brunocilla E., PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment, «CANCERS», 2023, 15, pp. 1 - 14 [Articolo in rivista] Open Access

Serani F.; Fendler W.P.; Castellucci P.; Berliner C.; Barbato F.; Herrmann K.; Farolfi A.; Fanti S., A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients, «CANCERS», 2023, 15, pp. 1 - 9 [Articolo in rivista] Open Access

Gillessen S.; Bossi A.; Davis I.D.; de Bono J.; Fizazi K.; James N.D.; Mottet N.; Shore N.; Small E.; Smith M.; Sweeney C.J.; Tombal B.; Antonarakis E.S.; Aparicio A.M.; Armstrong A.J.; Attard G.; Beer T.M.; Beltran H.; Bjartell A.; Blanchard P.; Briganti A.; Bristow R.G.; Bulbul M.; Caffo O.; Castellano D.; Castro E.; Cheng H.H.; Chi K.N.; Chowdhury S.; Clarke C.S.; Clarke N.; Daugaard G.; De Santis M.; Duran I.; Eeles R.; Efstathiou E.; Efstathiou J.; Ekeke O.N.; Evans C.P.; Fanti S.; Feng F.Y.; Fonteyne V.; Fossati N.; Frydenberg M.; George D.; Gleave M.; Gravis G.; Halabi S.; Heinrich D.; Herrmann K.; Higano C.; Hofman M.S.; Horvath L.G.; Hussain M.; Jereczek-Fossa B.A.; Jones R.; Kanesvaran R.; Kellokumpu-Lehtinen P.-L.; Khauli R.B.; Klotz L.; Kramer G.; Leibowitz R.; Logothetis C.; Mahal B.; Maluf F.; Mateo J.; Matheson D.; Mehra N.; Merseburger A.; Morgans A.K.; Morris M.J.; Mrabti H.; Mukherji D.; Murphy D.G.; Murthy V.; Nguyen P.L.; Oh W.K.; Ost P.; O'Sullivan J.M.; Padhani A, Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022, «EUROPEAN JOURNAL OF CANCER», 2023, 185, pp. 178 - 215 [Articolo in rivista] Open Access